INCY

INCYTE CORP

Services-Commercial Physical & Biological Research · SIC 8731CIK 879169Held by 9 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

Revenue FY2025

$5.14B

Net Income FY2025

$1.29B

EPS (Basic, as reported)

$6.59

Net Margin FY2025

25.0%

ROE FY2025

24.9%

Total Equity

$5.17B

Shares Out

200M

Business description

INCYTE CORP — Services-Commercial Physical & Biological Research. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2009–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions

default rows · click any row to chart itRevenue: 1,106 → 5,141 +18.6% CAGR

Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025

Revenue1,1061,5361,8822,1592,6672,9863,3953,6964,2415,141

Cost of revenue(58)(79)(94)(114)(131)(151)(207)(255)(312)(372)

Research & development(582)(1,326)(1,198)(1,154)(2,216)(1,458)(1,586)(1,628)(2,607)(2,050)

Selling, general & administrative(303)(366)(434)(469)(517)(740)(1,002)(1,161)(1,242)(1,376)

Total operating expenses(961)(1,780)(1,753)(1,757)(2,930)(2,400)(2,815)(3,075)(4,180)(3,626)

Operating income145(244)129402(264)586579621611,515

Interest expense(39)(7)(2)(2)(2)(2)(3)(3)(2)(2)

Interest & investment income——————40158129106

Other income (expense), net—1732522311401721325

Pre-tax income107(312)115487(232)5705298343171,664

Income tax expense(3)(1)(6)(40)(63)(378)(188)(237)(284)(378)

Net income104(313)109447(296)949341598331,287

EPS — basic$0.55($1.53)$0.52$2.08($1.36)$4.30$1.53$2.67$0.16$6.59

EPS — diluted$0.54($1.53)$0.51$2.05($1.36)$4.27$1.52$2.65$0.15$6.41

Shares outstanding — basic (M)188205212215218220222224207195

Shares outstanding — diluted (M)194205216218218222224226211201

Showing the latest 10 of 17 fiscal years.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.